Related Experiment Video
Updated: Jun 30, 2025

Heterokaryon Technique for Analysis of Cell Type-specific Localization
Published on: March 11, 2011
The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation
Baohui Zhu1, Ryota Ouda1, Ning An1
1Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Insights
Nuclear localization of NLRC5 is crucial for MHC class I expression. A balance between nuclear import and export, influenced by GCN5, regulates this process, offering therapeutic targets for cancer and viral diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Major histocompatibility complex (MHC) class I molecules are vital for adaptive immunity, presenting antigens to CD8 T cells.
- NLRC5 (NLR family, CARD domain-containing 5), also known as CITA, is a key regulator of MHC class I expression and antigen presentation.
- The nuclear localization of NLRC5 is essential for its transactivation function, but the precise regulatory mechanisms remain unclear.
Purpose of the Study:
- To elucidate the regulatory mechanisms governing the nuclear localization of NLRC5.
- To identify factors that control the balance between nuclear import and export of NLRC5.
- To explore the role of GCN5 (general control non-repressed 5 protein) in NLRC5 nuclear retention and MHC class I transactivation.
Main Methods:
- Comprehensive domain analysis of NLRC5 to investigate its localization.
- Experimental approaches to study the interplay between nuclear import and export mechanisms of NLRC5.
- Assays to determine the effect of GCN5 on NLRC5 nuclear retention and MHC class I expression.
Main Results:
- Nuclear import and export mechanisms for NLRC5 were found to coexist and counterbalance each other.
- GCN5, a histone acetyltransferase (HAT), was identified as a key factor in retaining NLRC5 within the nucleus.
- The nuclear retention of NLRC5 by GCN5 contributes significantly to the expression of MHC class I molecules.
Conclusions:
- The balance between NLRC5 import and export represents a novel regulatory layer for MHC class I transactivation.
- This regulatory mechanism, particularly the role of GCN5, presents a potential therapeutic target for enhancing immune responses in cancer and viral infections.
Abstract:
Major histocompatibility complex (MHC) class I molecules play an essential role in regulating the adaptive immune system by presenting antigens to CD8 T cells. CITA (MHC class I transactivator), also known as NLRC5 (NLR family, CARD domain-containing 5), regulates the expression of MHC class I and essential components involved in the MHC class I antigen presentation pathway. While the critical role of the nuclear distribution of NLRC5 in its transactivation activity has been known, the regulatory mechanism to determine the nuclear localization of NLRC5 remains poorly understood. In this study, a comprehensive analysis of all domains in NLRC5 revealed that the regulatory mechanisms for nuclear import and export of NLRC5 coexist and counterbalance each other. Moreover, GCN5 (general control non-repressed 5 protein), a member of HATs (histone acetyltransferases), was found to be a key player to retain NLRC5 in the nucleus, thereby contributing to the expression of MHC class I. Therefore, the balance between import and export of NLRC5 has emerged as an additional regulatory mechanism for MHC class I transactivation, which would be a potential therapeutic target for the treatment of cancer and virus-infected diseases.
More Related Videos
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Nuclear Localization Signals and Import
Directionality of Nuclear Transport
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Co-activators and Co-repressors

